ASX Equity Snapshot
BGT Weekly Equity Report
Bio-Gene Technology Limited
What the company does
Bio-Gene Technology Limited, an agtech development company, engages in the development and commercialization of naturally derived insecticide products in Australia and internationally. Its products include Flavocide, a synthetically produced nature-identical compound; and Qcide, a natural plant-derived oil with high levels of tasmanone. The company has a research collaboration agreement with James Cook University for experiments demonstrating the value of pre-conditioning biomass prior to distillation; Cesar for assessing the insecticidal activity of its molecules against a range of insect species; Advanced Molecular Technologies; CSIRO for a chemistry development process; the Department of Agriculture and Fisheries, Queensland …
What the weekly tape is saying
BGT closed the latest completed week at 0.02 AUD. The 4-week return is -21.4% and the 12-week return is -35.3%. Trend Signal is inactive, Market Dynamics is -0.73. Setup signature: Risk-first tape with a 22/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 0.03 AUD
- Vs Trend Line
- -26.4%
- Fair Value
- 0.05 AUD
- Vs Fair Value
- -51.5%
- 52W High
- 0.06 AUD
- 52W Low
- 0.02 AUD
- Drawdown
- -63.9%
- Range Position
- 13.3%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 30
- 52W Active Breadth
- 57.7%
- Sector Scope
- AU Healthcare
- Sector Rank
- 55 of 146
- Sector Percentile
- 62.8%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
AU Healthcare
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- -1.4%
- Avg 4W
- -3.6%
- Trend Breadth
- 15.0%
- Positive MD
- 39.0%
AU Biotechnology
- Tracked Peers
- 47
- 4W Rank
- 40 of 47
- Avg 1W
- -0.1%
- Avg 4W
- -5.8%
- Trend Breadth
- 10.6%
- Positive RS
- 21.3%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.73
- 4W MD Change
- -675.8%
- Relative Strength
- -20.08
- 4W RS Change
- -528.3%
- Expectation
- Negative
- Probability
- 37.14%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 3.6M
- 13W Average
- 1.3M
- 52W Average
- 1.4M
- Vs 13W
- 2.7x
- Vs 52W
- 2.6x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 10.2%
- 52W Volatility
- 11.2%
- Upside Weeks
- 20
- Downside Weeks
- 25
- Downside Breadth
- 48.1%
- Avg Gain / Loss
- 12.1% / -8.1%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- ASX
- Country
- AU
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- AUD
- Market Cap
- 8.5M
Opportunity signals
- Volume is elevated versus the 13-week average, confirming attention.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 0.02 AUD | 0.0% | 0.03 AUD | 0.05 AUD | -0.73 | -20.08 | 3.6M | Off |
| 5 Jun 2026 | 0.02 AUD | -21.4% | 0.03 AUD | 0.05 AUD | -0.72 | -18.34 | 4.7M | Off |
| 29 May 2026 | 0.03 AUD | -3.4% | 0.03 AUD | 0.05 AUD | -0.56 | 2.72 | 1.9M | Off |
| 22 May 2026 | 0.03 AUD | 3.6% | 0.03 AUD | 0.05 AUD | -0.25 | 7.70 | 1.7M | On |
| 15 May 2026 | 0.03 AUD | -17.6% | 0.03 AUD | 0.05 AUD | 0.13 | 4.69 | 555.2K | On |
| 8 May 2026 | 0.03 AUD | -8.1% | 0.03 AUD | 0.05 AUD | 0.65 | 25.94 | 407.0K | On |
| 1 May 2026 | 0.04 AUD | -2.6% | 0.03 AUD | 0.05 AUD | 0.72 | 38.23 | 414.3K | On |
| 24 Apr 2026 | 0.04 AUD | 0.0% | 0.03 AUD | 0.05 AUD | 0.70 | 42.12 | 375.9K | On |
| 17 Apr 2026 | 0.04 AUD | 22.6% | 0.03 AUD | 0.05 AUD | 0.60 | 40.63 | 789.8K | On |
| 10 Apr 2026 | 0.03 AUD | -6.1% | 0.03 AUD | 0.05 AUD | 0.63 | 15.32 | 227.4K | On |
| 3 Apr 2026 | 0.03 AUD | 3.1% | 0.03 AUD | 0.05 AUD | 0.83 | 27.72 | 306.2K | On |
| 27 Mar 2026 | 0.03 AUD | -5.9% | 0.03 AUD | 0.05 AUD | 1.00 | 24.10 | 697.8K | On |
| 20 Mar 2026 | 0.03 AUD | -2.9% | 0.03 AUD | 0.05 AUD | 1.06 | 32.91 | 1.6M | On |
| 13 Mar 2026 | 0.04 AUD | -5.4% | 0.03 AUD | 0.05 AUD | 0.89 | 33.72 | 61.1K | On |